However, because MMSET translocation in myeloma occurs early in the premalignant MGUS (Monoclonal Gammopathy of Undetermined Significance) stage of the disease, it is unclear to what extent fully developed tumors depend on MMSET expression or whether targeting MMSET can lead to tumor reduction. This evidence concerns the gene NSD2 and neoplasm.